Target intelligence / Profile preview

Bacterial membrane anionic lipids

Molecular classification
Lipid, Phospholipid
01

Overview

Bacterial membrane anionic lipids, primarily phosphatidylglycerol (PG) and cardiolipin (CL), are essential structural and functional components of the bacterial cytoplasmic membrane (Epand et al., 2016, Biochimica et Biophysica Acta). Unlike the plasma membranes of mammalian cells, which are predominantly composed of zwitterionic lipids like phosphatidylcholine on their outer leaflet, bacterial membranes maintain a high density of these negatively charged lipids (Houtkooper & Vaz, 2008, FEBS Letters). This fundamental biochemical difference provides a basis for the selective toxicity of many antimicrobial agents, including lipopeptides and cationic antimicrobial peptides (Straus & Hancock, 2006, Biochimica et Biophysica Acta). These lipids are involved in critical cellular processes such as the regulation of membrane fluidity, the anchoring of peripheral membrane proteins, and the coordination of cell division and bioenergetics (Mileykovskaya & Dowhan, 2009, Journal of Biological Chemistry). Drugs like daptomycin specifically require the presence of phosphatidylglycerol to insert into the membrane, where they cause rapid depolarization and cell death (Muller et al., 2016, PNAS). However, because cardiolipin is also a key component of eukaryotic mitochondrial membranes, therapeutic strategies must account for potential off-target effects and host toxicity (Paradies et al., 2014, Advances in Bioscience and Biotechnology).

Other names
Bacterial anionic phospholipidsAcidic phospholipidsPhosphatidylglycerolCardiolipin
02

Mechanism of action

Drugs targeting these lipids typically utilize electrostatic attraction to bind to the negatively charged headgroups, followed by hydrophobic insertion into the membrane core, which causes rapid depolarization, ion leakage, and disruption of essential membrane-bound processes (Muller et al., 2016, PNAS; Straus & Hancock, 2006, Biochimica et Biophysica Acta).

03

Biological functions

Membrane structural integrityCell divisionProtein localizationBioenergetics
04

Disease associations

Bacterial infection
05

Safety considerations

Myotoxicity (e.g., CPK elevation)NephrotoxicityCross-reactivity with mitochondrial cardiolipinEosinophilic pneumonia
06

Interacting drugs

Daptomycin

6 more in the full profile.

07

Biomarkers

Bacterial loadProcalcitonin levelsC-reactive protein

Beyond the preview

Go deeper on Bacterial membrane anionic lipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial membrane anionic lipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call